9th Annual Neurovascular Symposium

9th Annual Neurovascular Symposium

Live Conference at the John H. Ammon Medical Education Center, Newark, DE

Friday, September 13, 2024; 8:30am - 2:30pm

Registration Deadline: September 9, 2024 at noon (registration is required)

$75 Registration Fee
$35 Students
$0 Residents/Fellows of ChristianaCare
ChristianaCare cost center transfer for ChristianaCare employees only

Questions: Please contact Amy Minsker at amy.l.minsker@christianacare.org

 

Purpose

This symposium will cover new research and evidence-based practice in the care of strokes.
 

Target Audience

This activity is intended for primary care physicians, specialty physicians, nurses, nurse practitioners, physical and occupational therapists, and advanced practice providers.

Statement of Need

Recent research and advancements in the neurointerventional field have been published. New statewide protocols can improve the care statewide for stroke patients.  

Educational Objectives

Upon completion of this activity learners should be able to:

1. Identify and describe recent Delaware statewide advancement to improve the care of stroke patients.  
2. Describe best practices for the evaluation and treatment of atypical stroke presentations including small vessel disease and intercranial hemorrhage patients.
3. Identify recent neurointerventional advancements for challenging patients. 

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Society of Delaware and Christiana Care. The Medical Society of Delaware is accredited by the ACCME to provide continuing medical education for physicians.

It is the policy of the Medical Society of Delaware (MSD) to comply with the ACCME Standards for Commercial Support of Continuing Medical Education (CME). In keeping with these standards, all faculty participating in continuing medical education provided by MSD are expected to disclose to the activity audience any real or apparent conflicts of interest related to the content of their presentations.

Joint providership of CME by MSD in no way implies endorsement of any product or service. 

This activity is not supported by commercial funding.

.

Credit Designation Statement

The Medical Society of Delaware designates this live activity for a maximum of 5.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty and Disclosures

In accordance with the appropriate accrediting bodies, all planners, teachers, and authors with control over activity content are required to disclose to the provider any relevant financial relationships (those held by the planner or significant other, currently or within the last 24 months) with commercial interests/ineligible companies. Accredited providers are required to provide this information to learners before the start of an activity.

The following is a list of the faculty, along with any information they have disclosed regarding their relevant financial relationships.

Thinesh Sivapatham, MD (Planner, Activity Director, Speaker) - consultant for Penumbra, Inc - All of the relevant financial relationships listed for this individual have been mitigated.

Kimberly Parker Gannon, MD, PhD, FAHA, FACP (Planner, Speaker) - has no relevant financial relationship(s) with ineligible companies to disclose.
Douglas Huisenga, MPT, MSM/HCA (Planner) - has no relevant financial relationship(s) with ineligible companies to disclose.
Amy Minsker (Planner) - has no relevant financial relationship(s) with ineligible companies to disclose.

Robert A. Rosenbaum, MD, FAEMS (Speaker) - has no relevant financial relationship(s) with ineligible companies to disclose
Usman Shehzad, MD (Speaker) - has no relevant financial relationship(s) with ineligible companies to disclose
Shilpa Kauta, MD (Speaker) - has no relevant financial relationship(s) with ineligible companies to disclose
Franziska Herpich, MD (Speaker) - has no relevant financial relationship(s) with ineligible companies to disclose
Barbara Albani, MD (Speaker) - has no relevant financial relationship(s) with ineligible companies to disclose

Gaurav Jindal, MD (Speaker) - consultant/speaker for Stryker Neurovascular - All of the relevant financial relationships listed for this individual have been mitigated.

Sudhakar R. Satti, MD, FAHA (Speaker) - has no relevant financial relationship(s) with ineligible companies to disclose

Muhammad Shazam Hussain, MD, FRCP(C), FAHA (Speaker) - on advisory board for Cerenovus; consultant for Cerenovus, Stryker Neurovascular, Rapid Medical, Kaneka; Medtronic – Core lab PI for Evolve, Advance and Vantage trials; Data and Safety Monitoring Board (DSMB) for Stryker Neurovascular and Rapid Medical- All of the relevant financial relationships listed for this individual have been mitigated.

Christopher Kellner, MD (Speaker) - PI of the MIRROR Registry (Co-PIs Brian Jankowitz and Mark Bain; funded by Integra)
PI of the INSIGHT Registry (Co-PI Justin Fraser; funded by Penumbra)
PI of the MEMBRANE Trial (Co-PI Ansaar Rai; funded by Cerenovus)
PI of the TORNADO Trial (funded by Endostream)
PI of the VALOR Registry
PI of the CVA-FLOW Trial (funded by CVAID)
Co-I of the EVACUATE Trial (PIs Bruce Campbell and Timothy Kleinig; funded by the Australian Gov.)
Site PI of the GRASP Trial (funded by Microtransponder)
Site PI on the INVEST Trial (PI J Mocco)                                                                                                                                                                                      Received research grants from Penumbra, Integra, Minnetronix, Viz.AI, Siemens, Cerebrotech, Irras, Longevity, ICE Neurosystems, CVAID, Endostream, and Microtransponder; Has equity in Precision Recovery, Borealis, E8, Borvo, and Metis Innovative (all privately held). Metis Innovative is an investment group that has coordinated investments in Synchron, Proprio, Fluid Biomed, Von Vascular, Precision Recovery, Phantom Neuro, and Radical. - All of the relevant financial relationships listed for this individual have been mitigated.

Disclaimer

All information contained within this activity is intended for educational purposes only. Physicians and other health care professionals are encouraged to consult other sources and confirm the information contained in this educational event. No single reference or service can take the place of medical training, education and experience. This educational activity does not define a standard of care, nor is it intended to dictate an exclusive course of management. This information should not substitute for a visit or consultation with a health care provider.

Technical Requirements

This activity is best experienced using the most current browser of Firefox, Chrome, Safari, or Microsoft Edge. For all activities featuring audio you must have a sound card and speakers. To view graphic images and references that appear in separate "pop-up" windows, you must have JavaScript and session cookies enabled on your computer. Adobe Acrobat Reader may be required for certain activities.

Select the Continue button below to begin. You may return later if you are unable to complete the activity at this time.